A rare neuromuscular disease characterized by progressive muscle weakness with focal involvement of the facial, shoulder and limb muscles.
Synonyms:
Facioscapulohumeral myopathy
FSH dystrophy
FSHD
Landouzy-Dejerine myopathy
Landouzy-Dejerine dystrophy
Facioscapulohumeral muscular dystrophy
This is just here as a test because I lose it
Term information
database
cross reference
- ICD-11:8C70.3 (- E (Exact mapping: the two concepts are equivalent). - Specific code (The ORPHA code has its own code in the ICD).)
- OMIM:600416 (BTNT (ORPHA code's Broader Term maps to a Narrower Term))
- MedDRA:10064087 (E (Exact mapping: the two concepts are equivalent))
- OMIM:158900 (BTNT (ORPHA code's Broader Term maps to a Narrower Term))
- UMLS:C0238288 (E (Exact mapping: the two concepts are equivalent))
- ICD-10:G71.0 (- NTBT (ORPHA code's Narrower Term maps to a Broader Term). - Inclusion term (The ORPHA code is included under a ICD category and has not its own code).)
- OMIM:158901 (BTNT (ORPHA code's Broader Term maps to a Narrower Term))
definition citation
- Orphanet
expertlink
- https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=269
hasDbXref
- OMIM:600416
- OMIM:158900
- OMIM:158901
- ICD-11:8C70.3
- ICD-10:G71.0
- UMLS:C0238288
- MedDRA:10064087
has age of onset
- http://www.orpha.net/ORDO/Orphanet_409950
has annual incidence range
- http://www.orpha.net/ORDO/Orphanet_409976
has inheritance
- http://www.orpha.net/ORDO/Orphanet_409929
has point prevalence average value
- 12.0
- 3.95
- 2.0
- 4.5
- 4.4
has point prevalence range
- http://www.orpha.net/ORDO/Orphanet_409975
- http://www.orpha.net/ORDO/Orphanet_409977
notation
- ORPHA:269
part of
- http://www.orpha.net/ORDO/Orphanet_206644
present in
- http://www.orpha.net/ORDO/Orphanet_410100
- http://www.orpha.net/ORDO/Orphanet_410102
- http://www.orpha.net/ORDO/Orphanet_409984
- http://www.orpha.net/ORDO/Orphanet_410147
- http://www.orpha.net/ORDO/Orphanet_410224
Term relations
Subclass of:
Related from: